Patterns of opportunistic infections in patients with HIV infection

被引:39
作者
Finkelstein, DM
Williams, PL
Molenberghs, G
Feinberg, J
Powderly, WG
Kahn, J
Dolin, R
Cotton, D
机构
[1] JOHNS HOPKINS UNIV,BALTIMORE,MD
[2] WASHINGTON UNIV,ST LOUIS,MO
[3] SAN FRANCISCO GEN HOSP,SAN FRANCISCO,CA 94110
[4] UNIV ROCHESTER,ROCHESTER,NY
[5] MASSACHUSETTS GEN HOSP,BOSTON,MA 02114
来源
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY | 1996年 / 12卷 / 01期
关键词
opportunistic infections; Pneumocystis carinii pneumonia; Mycobacterium avium complex; cytomegalovirus infection; systemic mycosis; relative risk; prophylactic therapies; proportional hazards model;
D O I
10.1097/00042560-199605010-00006
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The pattern of the development of opportunistic infections (OIs) in HIV-infected patients was evaluated, based on a cohort of 1.530 patients enrolled in two AIDS Clinical Trials Group anti-retroviral studies. We quantified the increase in risk of OIs associated with the occurrence of a previous OI, This assessment was based on the observed event rates of the more common AIDS-defining OIs: Pneumocystis carinii pneumonia (PCP), Mycobacterium avium complex (MAC), cytomegalovirus (CMV), and a systemic mycosis. Additionally, for each OI, we assessed the relative risks associated with a history of prior OIs, changes in CD4 levels, and baseline prognostic factors. We found that the occurrence of each of these OIs increased the risk of subsequent OIs, even after adjusting for the CD4 count. Specifically, the occurrence of PCP significantly increased the risk of MAC and CMV and somewhat increased the risk of systemic mycoses. Diagnosis with MAC was associated with an increased risk of subsequent CMV. whereas the occurrence of CMV increased the risk of MAC. Finally, once patients were diagnosed with a systemic mycosis, they were at a somewhat increased risk of subsequently developing MAC or CMV. Although current practice for determining the timing and initiation of prophylactic therapies relies chiefly on CD4 count, the occurrence of specific AIDS-defining OIs in patients with HIV infection should also be taken into account in making decisions regarding prophylaxis strategies.
引用
收藏
页码:38 / 45
页数:8
相关论文
共 15 条
  • [1] EMERGENCE OF CANDIDA-KRUSEI INFECTIONS AFTER THERAPY OF OROPHARYNGEAL CANDIDIASIS WITH FLUCONAZOLE
    AKOVA, M
    AKALIN, HE
    UZUN, O
    GUR, D
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1991, 10 (07) : 598 - 599
  • [2] A RANDOMIZED TRIAL OF 3 ANTIPNEUMOCYSTIS AGENTS IN PATIENTS WITH ADVANCED HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION
    BOZZETTE, SA
    FINKELSTEIN, DM
    SPECTOR, SA
    FRAME, P
    POWDERLY, WG
    HE, WL
    PHILLIPS, L
    CRAVEN, D
    VANDERHORST, C
    FEINBERG, J
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (11) : 693 - 699
  • [3] Cotton D., 1992, AIDS Clinical Care, V4, P85
  • [4] COX DR, 1972, J R STAT SOC B, V34, P187
  • [5] DOLIN R, 1995, ARCH INTERN MED, V155, P961, DOI 10.1001/archinte.155.9.961
  • [6] FOGELMAN I, 1994, J ACQ IMMUN DEF SYND, V7, P1057
  • [7] INCIDENCE AND NATURAL-HISTORY OF CYTOMEGALOVIRUS DISEASE IN PATIENTS WITH ADVANCED HUMAN-IMMUNODEFICIENCY-VIRUS DISEASE TREATED WITH ZIDOVUDINE
    GALLANT, JE
    MOORE, RD
    RICHMAN, DD
    KERULY, J
    CHAISSON, RE
    BARTLETT, J
    MCAVINUE, S
    BRYSON, Y
    COHEN, H
    FISCHL, M
    BOLIN, T
    KESSLER, H
    BURROUGH, Y
    MILDVAN, D
    FOX, A
    RICHMAN, D
    FREEMAN, B
    SIMON, G
    GRABOWY, KW
    CHERNOFF, D
    DUFF, P
    THOMPSON, S
    BARRETT, K
    AWE, R
    CHAPMAN, R
    LEONARD, S
    BAINES, L
    TURNER, P
    HAWKINS, M
    MURRAY, H
    BOWERS, J
    LANE, C
    TILSON, H
    ANDREWS, E
    SMILEY, L
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1992, 166 (06) : 1223 - 1227
  • [8] SURVIVAL OF PATIENTS WITH ACQUIRED-IMMUNE-DEFICIENCY-SYNDROME AND DISSEMINATED MYCOBACTERIUM-AVIUM COMPLEX INFECTION WITH AND WITHOUT ANTIMYCOBACTERIAL CHEMOTHERAPY
    HORSBURGH, CR
    HAVLIK, JA
    ELLIS, DA
    KENNEDY, E
    FANN, SA
    DUBOIS, RE
    THOMPSON, SE
    [J]. AMERICAN REVIEW OF RESPIRATORY DISEASE, 1991, 144 (03): : 557 - 559
  • [9] A CONTROLLED TRIAL COMPARING CONTINUED ZIDOVUDINE WITH DIDANOSINE IN HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION
    KAHN, JO
    LAGAKOS, SW
    RICHMAN, DD
    CROSS, A
    PETTINELLI, C
    LIOU, SH
    BROWN, M
    VOLBERDING, PA
    CRUMPACKER, CS
    BEALL, G
    SACKS, HS
    MERIGAN, TC
    BELTANGADY, M
    SMALDONE, L
    DOLIN, R
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (09) : 581 - 587
  • [10] 2 CONTROLLED TRIALS OF RIFABUTIN PROPHYLAXIS AGAINST MYCOBACTERIUM-AVIUM COMPLEX INFECTION IN AIDS
    NIGHTINGALE, SD
    CAMERON, DW
    GORDIN, FM
    SULLAM, PM
    COHN, DL
    CHAISSON, RE
    ERON, LJ
    SPARTI, PD
    BIHARI, B
    KAUFMAN, DL
    STERN, JJ
    PEARCE, DD
    WEINBERG, WG
    LAMARCA, A
    SIEGAL, FP
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (12) : 828 - 833